Clinical responses in lung cancer patients have been impressive, with responses in patients with advance disease whose cancers did not respond to other treatment approaches. (hopkinsmedicine.org)
More advanced disease is associated with more complications and it can make treatment harder and more expensive. (meltonvet.com)
It depends on how advanced the disease is when diagnosed, how much organ damage has taken place, and how well patients have responded to standard treatment. (uofmhealthblogs.org)